The board of directors for University of North Carolina Health Care, based in Chapel Hill, has voted to decline WakeMed’s proposal to acquire Rex Healthcare in Raleigh, N.C. — part of UNC Health Care, according to a UNC news release.
The leadership of Raleigh-based WakeMed was notified of the decision today. According to the release, the board concluded that WakeMed’s proposal would “harm the quality of North Carolina’s patient care, increase cost to patients in the Wake County region and compromise the financial stability of UNC Health Care and the UNC School of Medicine,” according to the report.
WakeMed submitted a proposal to purchase Rex on May 12. A special committee appointed by UNC Health Care Board of Directors Chair Richard Krasno met several times to conduct a review of the proposal. Earlier today the special committee recommended to the full board that UNC decline the proposal.
“We hope to continue to build on the benefits of our partnership with WakeMed. Additional collaboration on issues such as pediatric care, mental health, hospitalist and expanded resident training, meeting the needs of the underserved and clinical data integration are promising avenues for us to explore,” Mr. Krasno said in the release.
Related Articles on Rex Healthcare and WakeMed:
UNC Health Care Forms Committee to Review WakeMed Offer
WakeMed Proposes Dec. 31 Acquisition of UNC Health Care’s Rex Healthcare
UNC Health Care Rejects WakeMed’s $750M Offer for Rex Healthcare
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
